Clinical Trials Directory

Trials / Completed

CompletedNCT04483037

Different Dosing Time of Bowklean for the Bowel Preparation

Comparison of Same-Day and Split-Dose Preparation With Sodium Picosulfate/Magnesium Citrate (Bowklean) for Afternoon Colonoscopy: A Randomized Non-Inferiority Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
297 (actual)
Sponsor
Changhua Christian Hospital · Academic / Other
Sex
All
Age
20 Years – 99 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to compare the efficacy of administration routine bowel cleansing medication (Bowklean) for the Bowel Preparation at Different Times Prior Colonoscopy in the morning or in the afternoon.

Detailed description

Sodium picosulfate/magnesium citrate (SPMC) is a small-volume bowel cleansing agent with similar efficacy and better tolerability than polyethylene glycol. However, there was limited data about the bowel cleansing efficacy of SPMC in comparing the same-day and split-dose preparation for afternoon colonoscopy. This randomized, single-center, endoscopist-blinded, non-inferior study compared same-day (101 subjects) and split-dose (96 subjects) preparation with SPMC for afternoon colonoscopy. One additional prospective observation group of 100 subjects receiving colonoscopy in the morning was included as an observation group to compare bowel preparation in morning and afternoon colonoscopy. Efficacy of bowel cleansing was evaluated by the Aronchick Scale, Ottawa Bowel Preparation Scale (OBPS), Boston Bowel Preparation Scale (BBPS), and the Bubble Scale (TBS).

Conditions

Interventions

TypeNameDescription
DRUGBowkleanassigned intervention

Timeline

Start date
2019-01-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2020-07-23
Last updated
2021-07-23

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04483037. Inclusion in this directory is not an endorsement.